Connecting Radiology | Enabling collaboration and professional development
3rd Annual Scientific Symposium on Nephrogenic Systemic Fibrosis and Gadolinium-based Contrast Agents (Yale)
Event Details
Time: May 9, 2009 all day
Location: New Haven, CT (Yale)
Street: 300 Cedar Street
City/Town: New Haven, CT
Website or Map: http://cme.yale.edu/conferenc…
Event Type: radiology, cme, and, dermatology
Organized By: Yale CME / Yale Radiology / Yale Dermatology
Latest Activity: May 9, 2009
Export to Outlook or iCal (.ics)
Event Description
3rd Annual Scientific Symposium on Nephrogenic Systemic Fibrosis and Gadolinium-based Contrast Agents
Dermatology, Diagnostic Radiology, and Internal Medicine, Section of Nephrology
In June 2006, the United States Food and Drug Administration (FDA) released a public health advisory cautioning against the use of gadolinium containing contrast agents (GCCA) in patients with severe renal disease. This advisory cited evidence suggesting an epidemiologic link between GCCA administration and the development of the emerging disease, Nephrogenic Systemic Fibrosis (NSF). NSF, first described in 2000, is a serious systemic disorder characterized by widespread tissue fibrosis. An international NSF registry at Yale University maintains records on over 310 patients with NSF worldwide. Over the past year, new information has emerged that directly impacts the clinical care and magnetic resonance imaging decision-making of patients with kidney disease.
The 3rd Annual Scientific Symposium on Nephrogenic Systemic Fibrosis and Gadolinium-based Contrast Agents†will educate physicians and allied health professionals concerning NSF. The conference faculty will impart further understanding of the link between NSF and GCCA. To achieve this objective, the specific goals of the symposium are to: 1) provide information on the diagnosis and treatment of NSF, 2) review current understanding of the pathophysiology of this disease, 3) present important differences among the various GCCA, 4) discuss the impact on patient care and practice management, and 5) discuss strategies to identify patients with kidney disease who might be at risk. This year, the faculty will include guest speakers from other US and European institutions, thereby greatly enriching the program and addressing global issues related to NSF.
Learning Objectives
Participants who attend this conference will be able to:
Review the latest diagnosis, clinical and epidemiological information about Nephrogenic Systemic Fibrosis (NSF)
Recognize the link between NSF and gadolinium-based contrast agents
Describe the potential mechanisms leading to NSF and new therapies
Discuss the current strategies to reduce risk and the recommendations from US and European work groups
Saturday, May 9, 2009
6 AMA PRA Catagory 1 Credits
The Anlyan Center for Medical Research and Education
300 Cedar Street
New Haven, CT
Registration Fees
Registration fee includes all conference materials, continental breakfast, refreshment breaks, and lunch.
$100 Physicians
$50 Nurses/Allied Health Professionals
$50 Patients
$50 Non-Yale Residents/Fellows*
Complimentary Yale Residents/Fellows*
*A letter of verification from department head must accompany registration. If registering online, letter should be sent separately to Yale CME address below.
All cancellations must be received in writing (or via email) at least one week prior to the start of the conference to receive a refund. Any requests for refunds received after this date, or by telephone, will not be honored.
Center for Continuing Medical Education
P.O. Box 7619
New Haven, CT
06519
Accreditation Statement
The Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians.
The American Medical Association has determined that physicians not licensed in the US who participate in this CME activity are eligible for AMA PRA Category 1 Credit.
Designation Statement
The Yale School of Medicine designates this educational activity for a maximum of 6 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Comment Wall
Comment
-
Comment by radRounds Radiology Network on March 25, 2009 at 11:53pm
-
3rd Annual Scientific Symposium on Nephrogenic Systemic Fibrosis and Gadolinium-based Contrast Agents
Schedule
8:00 am Registration and Continental Breakfast
8:45 am Welcome and Introduction
Ali Abu-Alfa MD
Dermatology and Pathology Axis
9:00 am Nephrogenic Systemic Fibrosis:
A Clinico-Pathologic Entity
Shawn Cowper MD and
Michael Girardi MD, PhD
9:40 am Detection of Gadolinium in Tissues
Jerrold Abraham MD
10:00 am Gadolinium Detection and
Clinico-Pathologic Correlates
Whitney A. High MD, MEng
10:20 am Panel Discussion
Moderator: Shawn Cowper MD
10:30 am Break
Basic Science, Epidemiology and Regulatory Axis
10:45 am NSF and GBCA: Regulatory Actions
in Denmark and the EU
Doris Stenver MD, MPA
11:05 am NSF and GBCA: Pharmacovigilance
and Regulatory Actions in the US
Charles C. Bennett MD, PhD
11:20 am Overview of Fibrocytes:
Role in health and Disease
Richard Bucala MD, PhD
11:35 am What can fibrocytes do for you?
Stem Cell Therapy for Treatment
of Cutaneous Lesions
Taehee Kwak MD
11:55 am Panel Discussion
Moderator: Phillip Kuo MD, PhD
12:15 pm Lunch and Poster Viewing
1:00 pm Invited Oral Presentations
Moderators: Jonathan Kay MD,
Jeffrey Weinreb MD
2:00 pm Pharmacokinetics of GBCA and
Animal models of NSF
Sameh K. Morcos FRCS, FFRRCSI, FRCR
2:30 pm Panel Discussion
Moderator: Michael Girardi MD, PhD
2:45 pm Poster-side Discussion and Break
Nephrology, Rheumatology and Radiology axis
3:15 pm Therapeutic Advances in NSF
Jonathan Kay MD
3:35 pm NSF and Gadolinium Based Contrast Agents:
US Perspective
Martin Prince MD, PhD
3:55 pm NSF and Gadolinium Based Contrast Agents:
European Perspective
Henrik Thomsen MD
4:15 pm Impact on the Care of Patients:
US Update
Ali Abu-Alfa MD
4:35 pm Strategies for Risk Reduction
Jeffrey Weinreb MD
4:55 pm Panel Discussion
Moderators: Shawn Cowper MD,
Phillip Kuo MD, PhD
5:00 pm Concluding Remarks and Adjourn
Ali Abu-Alfa MD
-
-
3rd Annual Scientific Symposium on Nephrogenic Systemic Fibrosis and Gadolinium-based Contrast Agents
Faculty
Symposium Chair
Ali K. Abu-Alfa MD, FASN
Associate Professor of Medicine
Department of Internal Medicine
Section of Nephrology
Yale School of Medicine
Scientific Program Co-Director
Shawn Cowper MD
Associate Professor of Dermatology and Pathology
Departments of Dermatology and Pathology
Yale School of Medicine
The International Center for Nephrogenic Fibrosing Deropathy Research (ICNFDR)
Clinical Program Co-Director
Jeffrey Weinreb MD
Professor of Diagnostic Radiology
Department of Diagnostic Radiology
Yale School of Medicine
Faculty
Jerrold Abraham MD
Professor of Pathology
SUNY Upstate Medical University
Richard Bucala MD, PhD
Professor of Medicine
Department of Internal Medicine
Section of Rheumatology
Yale School of Medicine
Charles Bennett MD, PhD
Professor of Medicine
Division of Hematology/Oncology
Northwestern University
Feinberg School of Medicine
Michael Girardi MD, PhD
Associate Professor of Dermatology
Department of Dermatology
Yale School of Medicine
Whitney A. High MD, MEng
Assistant Professor of Dermatology and Pathology
Departments of Dermatology & Pathology
University of Colorado School of Medicine
Research Professor of Chemistry and Geochemistry
Colorado School of Mines
Emanuel Kanal MD, FACR, FISMRM, AANG
(Abstract reviewer)
Director, Magnetic Resonance Services
Professor of Radiology and Neuroradiology
Department of Radiology
University of Pittsburgh Medical Center
Jonathan Kay MD
Associate Clinical Professor of Medicine
Rheumatology Unit
Massachusetts General Hospital
Phillip Kuo MD, PhD
Associate Professor of Medicine
University of Arizona School of Medicine
Taehee Kwak MD
Department of Dermatology and Skin Surgery
Roger Williams Medical Center
Sameh K. Morcos FRCS, FFRRCSI, FRCR
Professor of Diagnostic Imaging
University of Sheffield
Consultant Radiologist
Sheffield Teaching Hospitals
Martin Prince MD, PhD
Professor of Radiology
Weill Medical College of Cornell University
Chief of MRI
New York Hospital
Doris I. Stenver MD, MPA
Chief Medical Officer-Danish Medicine Agency
Member of the EU Pharmacovigilance Working Party
Henrik S. Thomsen MD
Professor of Radiology
Director, Department of Diagnostic Sciences
University of Copenhagen
Chairman, Department of Diagnostic Radiology
Copenhagen University Hospital
© 2024 Created by radRounds Radiology Network.
Powered by
RSVP for 3rd Annual Scientific Symposium on Nephrogenic Systemic Fibrosis and Gadolinium-based Contrast Agents (Yale) to add comments!
Join radRounds Radiology Network